- Home
- XFOR vs LCNB Comparison
XFOR vs LCNB Comparison
Compare XFOR & LCNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XFOR | LCNB |
|---|---|---|
| Founded | 2014 | 1877 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.5M | 281.1M |
| IPO Year | 2017 | 1999 |
Fundamental Metrics
Financial Performance| Metric | XFOR | LCNB |
|---|---|---|
| Price | $3.17 | $19.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | $11.60 | ★ $20.83 |
| AVG Volume (30 Days) | ★ 646.1K | 20.8K |
| Earning Date | 11-04-2026 | 10-15-2026 |
| Dividend Yield | N/A | ★ 4.51% |
| EPS Growth | N/A | ★ 68.04 |
| EPS | N/A | ★ 1.35 |
| Revenue | ★ $6,500,000.00 | $6,445,000.00 |
| Revenue This Year | N/A | $11.08 |
| Revenue Next Year | N/A | $0.51 |
| P/E Ratio | ★ N/A | $15.03 |
| Revenue Growth | ★ 150.00 | N/A |
| 52 Week Low | $2.43 | $14.83 |
| 52 Week High | $4.83 | $21.32 |
Technical Indicators
Market Signals| Indicator | XFOR | LCNB |
|---|---|---|
| Relative Strength Index (RSI) | 50.33 | 50.00 |
| Support Level | $2.83 | $19.25 |
| Resistance Level | $3.52 | $19.64 |
| Average True Range (ATR) | 0.26 | 0.55 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 53.47 | 40.62 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.